B族链球菌定植与抗菌药物耐药高发凸显即便实施产时抗生素预防指南后仍需接种疫苗
研究纳入2012至2020年台湾普遍B族链球菌筛查项目中5996名孕妇,调查定植率、耐药率及新生儿侵袭性感染发病率。平均定植率18.5%,红霉素耐药率9年间从35.5%升至45.5%,侵袭性感染发病率约0.6/1000活产(4/6204)。作者认为尽管产时抗生素预防后侵袭性感染发病率相对低,但定植率仍高且耐药增加,有效疫苗有望解决这些问题。
要点
- 平均B族链球菌定植率为18.5%,高龄组高于低龄组。
- 红霉素耐药率9年间从35.5%升至45.5%。
- 侵袭性B族链球菌病发病率约0.6/1000活产(4/6204)。
核心结论
- 实施产时抗生素预防后侵袭性B族链球菌病发病率相对低,但B族链球菌定植率仍高且抗菌药物耐药性在增加,作者认为有效疫苗有望解决这些问题。
研究设计与样本
- 研究纳入2012至2020年接受台湾普遍B族链球菌筛查项目的5996名孕妇,调查B族链球菌定植、抗菌药物耐药率及新生儿侵袭性B族链球菌感染发病率。
主要发现
- 平均B族链球菌定植率为18.5%,高龄组定植率高于低龄组。
- 来自印度尼西亚的移民女性阳性率高于台湾女性。
- 从越南女性分离的B族链球菌对克林霉素耐药显著高于台湾女性。
- 红霉素耐药率在9年测量期间从35.5%升至45.5%。
- 研究期间侵袭性B族链球菌病发病率约为0.6/1000活产(4/6204)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: It is estimated that about 11-35% of pregnant women are colonized with Group B streptococcus. Intrapartum antibiotic prophylaxis (IAP) is the primary intervention to decrease the risk of infecting babies born to GBS colonized mothers. METHODS: A total of 5,996 pregnant women, who received the Taiwanese universal GBS screening program from 2012 to 2020, were included in this study that investigated GBS colonization, antimicrobial resistance rates and their neonatal incidence of invasive GBS infection. RESULTS: The average GBS colonization rate was 18.5%. Older age groups had higher colonization rates than younger age groups. Compared to Taiwanese, immigrant women from Indonesia had a greater positive rate. GBS isolated from Vietnamese women had significant greater resistance to clindamycin relative to Taiwanese women. Rates of resistance to erythromycin increase from 35.5% to 45.5% over the 9 years of measurements. The incidence of invasive GBS disease was about 0.6/1,000 (4/6,204) live births during the study. CONCLUSIONS: Although relatively low incidence of invasive GBS diseases was observed after implementation of IAP, the colonization of GBS remains high and antimicrobial resistance of GBS is increasing. An effective GBS vaccine holds promise to be a solution for these issues.
引用
- Wang CH, Kung WJ, Lee CH, et al. High rates of colonization and antimicrobial resistance of group B streptococcus highlight the need for vaccination even after implementation of guidelines for intrapartum antibiotic prophylaxis. Vaccine. 2021. PMID: 34865875. doi:10.1016/j.vaccine.2021.11.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。